S&P 500   3,784.71 (-0.29%)
DOW   30,889.07 (-0.33%)
QQQ   314.86 (+0.16%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
S&P 500   3,784.71 (-0.29%)
DOW   30,889.07 (-0.33%)
QQQ   314.86 (+0.16%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
S&P 500   3,784.71 (-0.29%)
DOW   30,889.07 (-0.33%)
QQQ   314.86 (+0.16%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
S&P 500   3,784.71 (-0.29%)
DOW   30,889.07 (-0.33%)
QQQ   314.86 (+0.16%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
Log in
NASDAQ:SNOA

Sonoma Pharmaceuticals Short Interest Ratio and Short Volume

$8.10
-0.30 (-3.57 %)
(As of 01/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.10
Now: $8.10
$8.64
50-Day Range
$6.13
MA: $7.68
$9.08
52-Week Range
$3.55
Now: $8.10
$19.60
Volume84,627 shs
Average Volume55,637 shs
Market Capitalization$16.81 million
P/E RatioN/A
Dividend YieldN/A
Beta0.8

Short Interest

Sonoma Pharmaceuticals (NASDAQ:SNOA) Short Interest Data

Current Short Volume:582,200 shares
Previous Short Volume:3,900 shares
Change Vs. Previous Month:+14,828.21%
Dollar Volume Sold Short:$4.79 million
Short Interest Ratio / Days to Cover:1.0
Last Record Date:December, 31 2020
Outstanding Shares:11,970,000 shares
Float Size:2,060,000 shares
Short Percent of Float:28.26%
Today's Trading Volume:84,627 shares
Average Trading Volume:55,637 shares
Today's Volume Vs. Average:52.11%



Sonoma Pharmaceuticals (NASDAQ:SNOA) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
12/31/2020582,200 $4.79 million 14,828.2%28.3%0.6$8.23
12/15/2020582,200 $4.41 million 14,828.2%28.3%0.6$7.58
11/30/20203,900 $35,412.00 -44.3%0.2%0.1$9.08
11/15/20207,000 $47,180.00 -17.7%0.4%0.1$6.74
10/30/20208,500 $67,150.00 -48.8%0.4%0.1$7.90
10/15/202016,600 $128,484.00 8.5%0.8%0$7.74
9/30/202015,300 $131,274.00 -26.1%0.8%0$8.58
9/15/202020,700 $178,020.00 -39.3%1.0%0$8.60
8/31/202034,100 $242,110.00 -7.1%1.7%0.1$7.10
8/14/202036,700 $266,075.00 -93.1%1.8%0$7.25
7/31/2020532,600 $4.55 million 3,089.2%27.5%0.5$8.55
7/15/202016,700 $153,306.00 9.9%0.9%0$9.18
6/30/202015,200 $100,624.00 223.4%0.9%0$6.62
6/15/20204,700 $32,477.00 30.6%0.3%0$6.91
5/29/20203,600 $25,056.00 414.3%0.2%0$6.96
5/15/2020700 $6,790.00 -46.2%0.0%0$9.70
4/30/20201,300 $7,007.00 -82.4%0.1%0.1$5.39
4/15/20207,400 $38,702.00 -30.8%0.4%0.3$5.23
3/31/202010,700 $51,039.00 435.0%0.6%0.4$4.77
3/13/20202,000 $10,800.00 66.7%0.1%0.1$5.40
2/28/20201,200 $7,260.00 9.1%0.1%0$6.05
2/14/20201,100 $6,039.00 57.1%0.1%0$5.49
1/31/2020700 $3,549.00 -87.0%0.1%0$5.07
1/15/20205,400 $27,648.00 145.5%0.4%0.2$5.12
12/31/20192,200 $12,518.00 -37.1%0.2%0.1$5.69

Sonoma Pharmaceuticals (NASDAQ:SNOA) Short Interest FAQ

speech bubbles
speech bubbles











What is Sonoma Pharmaceuticals' current short interest?

Short interest is the volume of Sonoma Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 582,200 shares of SNOA short. 28.26% of Sonoma Pharmaceuticals' shares are currently sold short. View details.

What is a good short interest ratio for Sonoma Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Sonoma Pharmaceuticals currently has a short interest ratio of 1.0.

What is a good short interest percentage for Sonoma Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 28.26% of Sonoma Pharmaceuticals' floating shares are currently sold short.

Is Sonoma Pharmaceuticals' short interest increasing or decreasing?

Sonoma Pharmaceuticals saw a increase in short interest in December. As of December 31st, there was short interest totaling 582,200 shares, an increase of 14,828.2% from the previous total of 3,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Sonoma Pharmaceuticals' float size?

Sonoma Pharmaceuticals currently has issued a total of 2,075,000 shares. Some of Sonoma Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sonoma Pharmaceuticals currently has a public float of 2,060,000 shares.

How does Sonoma Pharmaceuticals' short interest compare to its competitors?

28.26% of Sonoma Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Sonoma Pharmaceuticals: RegeneRx Biopharmaceuticals, Inc. (0.00%), CohBar, Inc. (0.00%), BioLineRx Ltd. (0.00%), Daré Bioscience, Inc. (0.00%), CV Sciences, Inc. (0.00%), Citius Pharmaceuticals, Inc. (0.00%), Moleculin Biotech, Inc. (0.00%), Zosano Pharma Co. (0.00%), Acasti Pharma Inc. (0.53%), and PDS Biotechnology Co. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

What does it mean to sell short Sonoma Pharmaceuticals stock?

Short selling SNOA is an investing strategy that aims to generate trading profit from Sonoma Pharmaceuticals as its price is falling. Sonoma Pharmaceuticals' stock is trading down $0.30 today. To short Sonoma Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Sonoma Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Sonoma Pharmaceuticals?

A short squeeze for Sonoma Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNOA, which in turn drives the price of the stock up even further.

How often is Sonoma Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNOA, twice per month. The most recent reporting period available is December, 31 2020.


This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.